Estrella, Cherlyn M.
Background/Rationale Pancreatic cancer is a malignant neoplasm of the pancreas. Each year in the United States, about 42,470 individuals are diagnosed with this condition and 35,240 die from the disease. The prognosis is generally poor; less than 5 percent of those diagnosed are still alive five years after diagnosis. Further, it is among the five leading causes of cancer-related death among men and women in Europe and USA.
Therefore, preoperative staging must provide reliable information about the extent of the disease. In many centers, helical contrast-enhanced computed tomography (CT) is established as the most efficacious initial staging study in suspected pancreatic cancer. However, the need for preoperative biopsy of suspected pancreatic cancer is controversial especially in potentially resectable tumors.
The first article talks about how preoperative biopsy results may affect the management of patients with a suspected malignant lesion of the pancreas. Based on the chart, the patient had undergone different diagnostic procedures including a biopsy. This article may help nurses and other health care team members in managing patients with pancreatic tumor. The next article talks about the latest advancement in performing total pancreatectomywhich is the most effective treatment for pancreatic cancer. Management of patients with pancreatic cancer is critical since it is considered to be the most lethal form of gastrointestinal malignancy.
Problem Statement Main problem: How can you effectively manage patients with pancreatic tumor?
What are the possible complications of having preoperative biopsy?
What are the differences of the new laparoscopic pancreatectomy technique from the traditional one?
What are the advantages, on the side of the patient, from undergoing laparoscopic pancreatectomy?
Summary Total Pancreatectomy: Doing It with a...